Inventor · disambiguated record
Kateri A. Ahrendt
Also filed as: AHRENDT KATERI · AHRENDT KATERI A
8 granted patents·2 pending applications·75 citations·filing 2000–2014
86Inventor score
Top patents by PatentIndex Score
10 records- 0190US6307057B1Acid addition salts of imidazolidinones as reaction catalystsUNIV CALIFORNIA·Filed 2000·Granted Oct 23, 2001·21 cites·17 claims
- 0282US8324257B2Mitotic kinesin inhibitors and methods of use thereofAHRENDT KATERI·Filed 2007·Granted Dec 4, 2012·7 cites·37 claims
- 0382US6534434B2Chiral imidazolidinone-based catalyst composition and reaction systemUNIV CALIFORNIA·Filed 2001·Granted Mar 18, 2003·11 cites·36 claims
- 0479US6369243B1Chemical transformation of substrates using nonmetallic, organic catalyst compositionsUNIVERISITY OF CALIFORNIA·Filed 2000·Granted Apr 9, 2002·21 cites·74 claims
- 0577US8394795B2Pyrazole [3, 4-B] pyridine Raf inhibitorsAHRENDT KATERI A·Filed 2009·Granted Mar 12, 2013·5 cites·45 claims
- 0676US8338452B2Raf inhibitor compounds and methods of use thereofAHRENDT KATERI A·Filed 2009·Granted Dec 25, 2012·4 cites·49 claims
- 0765US6515137B2Catalytic processes employing chiral imidazolidinone-based catalyst compositionUNIV CALIFORNIA·Filed 2001·Granted Feb 4, 2003·6 cites·46 claims
- 0849US2011003859A1N- (6-aminopyridin-3-yl) -3- (sulfonamido) benzamide derivatives as b-raf inhibitors for the treatment of cancerARRAY BIOPHARMA INC·Filed 2009·Application pending·0 cites
- 0949US2011003809A1Imidazo [4,5-b] pyridine derivatives used as raf inhibitorsARRAY BIOPHARMA INC·Filed 2009·Application pending·0 cites
- 1045US9394254B2Antibiotic and anti-parasitic agents that modulate class II fructose 1,6-bisphosphate aldolaseCOLORADO SEMINARY·Filed 2014·Granted Jul 19, 2016·0 cites·11 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →